By Will Soutter
Market research information and reports provider, Research and Markets has announced the inclusion of the "The 2012 Hematology and Flow Cytometry Markets: US, Europe, Japan Emerging Opportunities and Business Expansion Strategies" to its report portfolio.
The 700 page report comprises 250 tables and includes information not published anywhere else. The report will aid existing suppliers and future market entrants to recognize and assess potential opportunities in the hematology and flow cytometry markets in the coming decade. The report encompasses forecasts of marketing and technological trends segment wise, in seven countries. It provides forecasts of test volumes by assay, offers details of market share estimates, information on instrument placements and also includes profiles of emerging entrants and leading players of the industry.
The developments in monoclonal antibodies, molecular diagnostics, IT and laser technology coupled with the growing insight into immunologic factors shaping systemic diseases is expected to change the global hematology and flow cytometry markets in the next decade. Monoclonal antibody and molecular diagnostic tests are expected to pave the way for simple and sensitive assays. Smaller and conveniently operable laser systems are expected to expand the scope of flow cytometry applications to regular clinical laboratories. Current procedures of DNA analysis are also expected to become less tedious.